Search

Your search keyword '"Martinez-Prieto, Marcela"' showing total 5 results
Start Over Author "Martinez-Prieto, Marcela"
5 results on '"Martinez-Prieto, Marcela"'

2. Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study

Author

Schuster, Stephen J, Tam, Constantine S, Borchmann, Peter, Worel, Nina, McGuirk, Joseph P, Holte, Harald, Waller, Edmund K, Jaglowski, Samantha, Bishop, Michael R, Damon, Lloyd E, Foley, Stephen Ronan, Westin, Jason R, Fleury, Isabelle, Ho, P Joy, Mielke, Stephan, Teshima, Takanori, Janakiram, Murali, Hsu, Jing-Mei, Izutsu, Koji, Kersten, Marie José, Ghosh, Monalisa, Wagner-Johnston, Nina, Kato, Koji, Corradini, Paolo, Martinez-Prieto, Marcela, Han, Xia, Tiwari, Ranjan, Salles, Gilles, and Maziarz, Richard T

Published
2021
Full Text
View/download PDF

3. Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison

Author

Schuster, Stephen J., primary, Zhang, Jie, additional, Yang, Hongbo, additional, Agarwal, Abhijit, additional, Tang, Wenxi, additional, Martinez-Prieto, Marcela, additional, Bollu, Vamsi, additional, Kuzan, David, additional, Maziarz, Richard T., additional, and Kersten, Marie José, additional

Published
2022
Full Text
View/download PDF

4. Comparative efficacy of tisagenlecleucel (tisa-cel) and lisocabtagene maraleucel (liso-cel) in patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL).

Author

Schuster, Stephen J., primary, Zhang, Jie, additional, Yang, Hongbo, additional, Agarwal, Abhijit, additional, Tang, Wenxi, additional, Martinez-Prieto, Marcela, additional, Bollu, Vamsi, additional, Ma, Qiufei, additional, Kuzan, David, additional, Maziarz, Richard T., additional, and Kersten, Marie José, additional

Published
2021
Full Text
View/download PDF

5. Safety and efficacy of tisagenlecleucel (tisa-cel) plus pembrolizumab (pembro) in patients (pts) with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): Updated analysis of the phase 1b PORTIA study.

Author

Jäger, Ulrich, primary, Worel, Nina, additional, McGuirk, Joseph, additional, Riedell, Peter A., additional, Fleury, Isabelle, additional, Borchmann, Peter, additional, Du, Yan, additional, Abdelhady, Ahmed M., additional, Han, Xia, additional, Martinez-Prieto, Marcela, additional, and Waller, Edmund K., additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results